Explore All Access
Check if your research matches the topics covered in In Vivo?
- Degree of match
- Common matching concepts
- Additional journal recommendations
In Vivo : Impact Factor & More
eISSN: 1791-7549pISSN: 0258-851X
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
In Vivo Key Metrics
CiteScore 
3.1
SNIP
0.84
In Vivo Journal Specifications
| Overview | |
| Publisher | INT INST ANTICANCER RESEARCH |
| Language | English |
| Frequency | Bi-monthly |
| General Details |
View less
Planning to publish in In Vivo ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in In Vivo
Histopathological Correlation Between High Endothelial Venule Neogenesis and the Tumor Microenvironment in Lung Adenocarcinoma.
- 29 Oct 2024
- In vivo (Athens, Greece)
Accurate and Safe Tumor Targeting of Orally-administered Salmonella typhimurium A1-R Leads to Regression of an Aggressive Fibrosarcoma in Nude Mice.
- 29 Oct 2024
- In vivo (Athens, Greece)
Molecular Hydrogen Therapy in Aneurysmal SAH With RA and Newly-diagnosed SLE, Complicated With Acute Ischemic Infarction: A Case Report of Improved Immune Markers Including Tr1 Cells, Breg Cells and TIM3 Expression on Tc Cells.
- 29 Oct 2024
- In vivo (Athens, Greece)
Prognostic Predictors of Hypertension Outcomes After Adrenalectomy in Primary Aldosteronism.
- 29 Oct 2024
- In vivo (Athens, Greece)
Clinical Outcomes of Pleomorphic High-grade Squamous Intraepithelial Lesions of the Uterine Cervix: A Single-institutional Experience of 44 Cases.
- 29 Oct 2024
- In vivo (Athens, Greece)
Management of Recurrent Vancomycin-resistant Enterococcus faecium Bacteremia With Oritavancin: A Case Report.
- 29 Oct 2024
- In vivo (Athens, Greece)
Histopathological Correlation Between High Endothelial Venule Neogenesis and the Tumor Microenvironment in Lung Adenocarcinoma.
- 29 Oct 2024
- In vivo (Athens, Greece)
Accurate and Safe Tumor Targeting of Orally-administered Salmonella typhimurium A1-R Leads to Regression of an Aggressive Fibrosarcoma in Nude Mice.
- 29 Oct 2024
- In vivo (Athens, Greece)
Molecular Hydrogen Therapy in Aneurysmal SAH With RA and Newly-diagnosed SLE, Complicated With Acute Ischemic Infarction: A Case Report of Improved Immune Markers Including Tr1 Cells, Breg Cells and TIM3 Expression on Tc Cells.
- 29 Oct 2024
- In vivo (Athens, Greece)
Prognostic Predictors of Hypertension Outcomes After Adrenalectomy in Primary Aldosteronism.
- 29 Oct 2024
- In vivo (Athens, Greece)
Clinical Outcomes of Pleomorphic High-grade Squamous Intraepithelial Lesions of the Uterine Cervix: A Single-institutional Experience of 44 Cases.
- 29 Oct 2024
- In vivo (Athens, Greece)
Management of Recurrent Vancomycin-resistant Enterococcus faecium Bacteremia With Oritavancin: A Case Report.
- 29 Oct 2024
- In vivo (Athens, Greece)
FAQs on In Vivo
How long has In Vivo been actively publishing? 
In Vivo has been in operation since 1987 till date.
What is the publishing frequency of In Vivo?
In Vivo published with a Bi-monthly frequency.
How many articles did In Vivo publish last year?
In 2024, In Vivo publsihed 113 articles.
What is the eISSN & pISSN for In Vivo?
For In Vivo, eISSN is 1791-7549 and pISSN is 0258-851X.
What is Citescore for In Vivo?
Citescore for In Vivo is 3.1.
What is SNIP score for In Vivo?
SNIP score for In Vivo is 0.84.
Who is the publisher of In Vivo?
INT INST ANTICANCER RESEARCH is the publisher of In Vivo.
